HK Stock Market Move | MANULIFE-S (00945) rose nearly 3% after earnings, with core earnings in the second quarter increasing by 12% year-on-year. The company continues to advance its strategic priorities.

MANULIFE-S (00945) rose nearly 3% after the earnings report, and as of the time of writing, it has increased by 2.33%, priced at HKD 351, with a transaction volume of HKD 10.069 million. On August 6, MANULIFE-S released its second quarter results as of June 30, 2026. Core earnings reached CAD 1.9 billion, representing a 12% increase compared to the second quarter of 2025 based on fixed exchange rates; the net income attributable to shareholders was CAD 2.1 billion, an increase of CAD 300 million compared to the second quarter of 2025; core EPS was CAD 1.09, up 16% from the second quarter of 2025; EPS was CAD 1.20, up 22% from the second quarter of 2025; core ROE was 16.3%, and ROE was 18.0%; the "Life Insurance Capital Adequacy Test" (LICAT) ratio was 136%. The announcement stated that Manulife's strong performance in the second quarter continues to advance its strategic priorities. The company's core EPS grew 16% year-on-year in the second quarter, with all three insurance business segments achieving double-digit revenue growth, showcasing the strength of its diversified business portfolio. Core earnings in Asia grew by 21%, and three newly generated business metrics also achieved double-digit increases; the profitability of the global wealth and asset management business expanded, and it recorded net inflows, with the recently acquired CQS and Comvest businesses contributing significantly.